Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Accounts Receivable, Allowance for Credit Loss, Current	$ 5	$ 5
Common stock, shares authorized (in shares)	1,200,000,000	1,200,000,000
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Preferred Stock, Shares Issued	1,043,050	1,043,050
Preferred Stock, Shares Authorized	50,000,000	50,000,000
Accounts receivable, net of allowance for doubtful accounts of $5 and $5, respectively	$ 5	$ 5
Other intangible assets, net of accumulated amortization of $455 and $434, respectively	455	434
Other Noncurrent Assets, Allowance	$ 46	$ 51
Preferred Stock, Shares Outstanding	1,043,050	1,043,050
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares issued (in shares)	818,808,272	818,790,001
Common stock, shares outstanding (in shares)	669,335,716	668,743,464
Variable Interest Entity [Line Items]
Non-recourse debt, including $314 and $416, respectively, related to variable interest entities	$ 1,737	$ 1,758
Non-recourse debt, including $2,413 and $2,295, respectively, related to variable interest entities	18,513	17,846
Consolidated Variable Interest Entities [Member]
Variable Interest Entity [Line Items]
Non-recourse debt, including $314 and $416, respectively, related to variable interest entities	314	416
Non-recourse debt, including $2,413 and $2,295, respectively, related to variable interest entities	$ 2,413	$ 2,295